---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-030112"
form_type: "8-K"
ticker: "HOOK"
cik: "0001760542"
company_name: "HOOKIPA Pharma Inc."
filed_at: "2022-03-03T23:59:59+00:00"
generated_at: "2026-06-27T02:04:39.009338+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# HOOKIPA Pharma prices $75M public offering of common stock and convertible preferred stock

## Summary
- Issued 21.7M common shares at $2.00/share and 15,800 Series A-1 convertible preferred shares at $2,000 each (each convertible into 1,000 common shares).
- Gross proceeds $75M; net proceeds expected ~$70M after underwriting discounts and expenses.
- Offering expected to close March 4, 2022; underwriters have 30-day option for up to 5.625M additional common shares.
- After offering, shares outstanding will be 50,868,668, excluding the underwriters' option.
- SVB Leerink and RBC Capital Markets acted as joint book-running managers.

## SEC filing metadata
- accession: 0001104659-22-030112
- form_type: 8-K
- ticker: HOOK
- cik: 0001760542
- company_name: HOOKIPA Pharma Inc.
- filed_at: 2022-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760542/000110465922030112/0001104659-22-030112-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760542/000110465922030112/tm227839d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-030112
- JSON: https://secwatch.observer/filing/0001104659-22-030112.json
- Plain text: https://secwatch.observer/filing/0001104659-22-030112.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.